Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Depreciation & Amortization (CF) (2016 - 2026)

Ocular Therapeutix has reported Depreciation & Amortization (CF) over the past 14 years, most recently at $1.3 million for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 30.78% year-over-year to $1.3 million; the TTM value through Mar 2026 reached $4.6 million, up 20.36%, while the annual FY2025 figure was $4.3 million, 14.18% up from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $1.3 million at Ocular Therapeutix, up from $1.2 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.3 million in Q1 2026 and troughed at $483000.0 in Q1 2023.
  • A 5-year average of $852176.5 and a median of $951000.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 14.31% in 2022 and later surged 95.11% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $491000.0 in 2022, then soared by 95.11% to $958000.0 in 2023, then decreased by 0.73% to $951000.0 in 2024, then skyrocketed by 31.13% to $1.2 million in 2025, then rose by 2.89% to $1.3 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for OCUL at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.